Pulmonary hypertension associated with benfluorex exposure
Benfluorex was marketed in France until 2009, despite its similar pharmacological properties with fenfluramine and its derivatives known to be a cause of pulmonary arterial hype...
Publications
View AllInstitution Info
- Type
- healthcare
- Country
- FR
- Publications
- 1
- Citations
- 90
External Links
Identifiers
- ROR
- https://ror.org/047wq3n50